Narcisi, R <br/><br/>
TGFβ inhibition during expansion phase increases the chondrogenic re-differentiation capacity of human articular chondrocytes.  [electronic resource] 

 -  Osteoarthritis and cartilage  Oct 2012 
 - 1152-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1522-9653 
<br/><br/><label>Standard No.: </label>10.1016/j.joca.2012.06.010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Blocking--pharmacology<br/>Benzamides--pharmacology<br/>Biomarkers--metabolism<br/>Cartilage, Articular--cytology<br/>Cell Culture Techniques<br/>Cell Differentiation--drug effects<br/>Cell Enlargement--drug effects<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Chondrocytes--cytology<br/>Culture Media--chemistry<br/>Culture Media, Serum-Free<br/>Humans<br/>Hypertrophy--chemically induced<br/>Knee Injuries--metabolism<br/>Osteoarthritis, Knee--metabolism<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology<br/>Smad Proteins--antagonists & inhibitors<br/>Transforming Growth Factor beta--antagonists & inhibitors